|
Total (n)
|
27
|
10
|
|
Male:female ratio
|
3:6
|
3:7
|
|
Age (y)
|
57 ± 13
|
54 ± 9
|
|
Body surface area (BSA, m2)
|
1.81 ± 0.16
|
1.78 ± 0.21
|
|
Heart rate (bpm)
|
76 ± 11
|
64 ± 7 †
|
|
Cardiac index (L/min/m2)
|
3.3 ± 0.8
|
3.5 ± 0.6
|
|
LV stroke volume index (mL/m2)
|
44 ± 11
|
54 ± 7
|
|
LV end diastolic volume index (mL/m2)
|
72 ± 16
|
89 ± 10
|
|
LV end systolic volume index (mL/m2)
|
29 ± 9
|
35 ± 4
|
|
LV ejection fraction (%)
|
61 ± 8
|
60 ± 3
|
|
RV stroke volume index (mL/m2)
|
42 ± 8
|
53 ± 7 ‡
|
|
RV end diastolic volume index (mL/m2)
|
79 ± 23
|
83 ±11
|
|
RV end systolic volume index (mL/m2)
|
37 ± 22
|
30 ± 7
|
|
RV ejection fraction (%)
|
55 ± 13
|
64 ± 6
|
|
Duration of disease (y)
|
6 ± 8
| |
|
Limited cutaneous SSc (n (%))
|
18 (67)
| |
|
Diffuse cutaneous SSc (n (%))
|
3 (11)
| |
|
Early SSc (n (%))
|
6 (22)
| |
|
PAH (n (%))
|
1 (4)
| |
